<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35361972</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1726</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3'UTR protect against ALS.</ArticleTitle><Pagination><StartPage>433</StartPage><EndPage>445</EndPage><MedlinePgn>433-445</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41593-022-01040-6</ELocationID><Abstract><AbstractText>The noncoding genome is substantially larger than the protein-coding genome but has been largely unexplored by genetic association studies. Here, we performed region-based rare variant association analysis of &gt;25,000 variants in untranslated regions of 6,139 amyotrophic lateral sclerosis (ALS) whole genomes and the whole genomes of 70,403 non-ALS controls. We identified interleukin-18 receptor accessory protein (IL18RAP) 3' untranslated region (3'UTR) variants as significantly enriched in non-ALS genomes and associated with a fivefold reduced risk of developing ALS, and this was replicated in an independent cohort. These variants in the IL18RAP 3'UTR reduce mRNA stability and the binding of double-stranded RNA (dsRNA)-binding proteins. Finally, the variants of the IL18RAP 3'UTR confer a survival advantage for motor neurons because they dampen neurotoxicity of human induced pluripotent stem cell (iPSC)-derived microglia bearing an ALS-associated expansion in C9orf72, and this depends on NF-&#x3ba;B signaling. This study reveals genetic variants that protect against ALS by reducing neuroinflammation and emphasizes the importance of noncoding genetic association studies.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Eitan</LastName><ForeName>Chen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6952-0336</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Siany</LastName><ForeName>Aviad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barkan</LastName><ForeName>Elad</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Computer Science And Applied Math, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olender</LastName><ForeName>Tsviya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Eijk</LastName><ForeName>Kristel R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moisse</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8880-9311</Identifier><AffiliationInfo><Affiliation>KU Leuven - University of Leuven, Department of Neurosciences, Experimental Neurology, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farhan</LastName><ForeName>Sali M K</ForeName><Initials>SMK</Initials><AffiliationInfo><Affiliation>Analytic and Translational Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danino</LastName><ForeName>Yehuda M</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanowski</LastName><ForeName>Eran</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marmor-Kollet</LastName><ForeName>Hagai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivkin</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yacovzada</LastName><ForeName>Nancy Sarah</ForeName><Initials>NS</Initials><Identifier Source="ORCID">0000-0002-5152-8775</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science And Applied Math, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Shu-Ting</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research at USC, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zilkha Neurogenetic Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper-Knock</LastName><ForeName>Johnathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0873-8689</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chien-Hsiung</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Louis</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8382-6358</Identifier><AffiliationInfo><Affiliation>Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masters</LastName><ForeName>Seth L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0003-4763-576X</Identifier><AffiliationInfo><Affiliation>Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenna</LastName><ForeName>Kevin P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Spek</LastName><ForeName>Rick A A</ForeName><Initials>RAA</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sproviero</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>King's College London, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology &amp; Neuroscience, De Crespigny Park, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Khleifat</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7406-9831</Identifier><AffiliationInfo><Affiliation>King's College London, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology &amp; Neuroscience, De Crespigny Park, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacoangeli</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King's College London, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology &amp; Neuroscience, De Crespigny Park, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shatunov</LastName><ForeName>Aleksey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King's College London, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology &amp; Neuroscience, De Crespigny Park, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Ashley R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0003-0470-0058</Identifier><AffiliationInfo><Affiliation>King's College London, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology &amp; Neuroscience, De Crespigny Park, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elbaz-Alon</LastName><ForeName>Yael</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6267-9800</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Yahel</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chapnik</LastName><ForeName>Elik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothschild</LastName><ForeName>Daphna</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0872-8624</Identifier><AffiliationInfo><Affiliation>Department of Computer Science And Applied Math, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Developmental Biology, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weissbrod</LastName><ForeName>Omer</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Computer Science And Applied Math, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beck</LastName><ForeName>Gilad</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ainbinder</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben-Dor</LastName><ForeName>Shifra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9604-1939</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werneburg</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Brudnick Neuropsychiatric Research Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schafer</LastName><ForeName>Dorothy P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Brudnick Neuropsychiatric Research Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials><Suffix>Jr</Suffix><Identifier Source="ORCID">0000-0001-6062-1528</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Pamela J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4010-2357</Identifier><AffiliationInfo><Affiliation>KU Leuven - University of Leuven, Department of Neurosciences, Experimental Neurology, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospitals Leuven, Department of Neurology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phatnani</LastName><ForeName>Hemali</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Eran</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6859-1164</Identifier><AffiliationInfo><Affiliation>Department of Computer Science And Applied Math, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichida</LastName><ForeName>Justin K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research at USC, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zilkha Neurogenetic Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4924-7712</Identifier><AffiliationInfo><Affiliation>King's College London, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology &amp; Neuroscience, De Crespigny Park, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College Hospital, Denmark Hill, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldink</LastName><ForeName>Jan H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5572-9657</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Project MinE ALS Sequencing Consortium</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>NYGC ALS Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Hornstein</LastName><ForeName>Eran</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5534-1924</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. Eran.hornstein@weizmann.ac.il.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel. Eran.hornstein@weizmann.ac.il.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/R024804/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS111990</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS097850</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS073873</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/L501529/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>ALCHALABI-DOBSON/APR14/829-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS104022</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020413">3' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C115629">IL18RAP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053728">Interleukin-18 Receptor beta Subunit</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020413" MajorTopicYN="N">3' Untranslated Regions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053728" MajorTopicYN="N">Interleukin-18 Receptor beta Subunit</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>
<b>Competing interests</b>
. J.K.I. is a cofounder of AcuraStem Incorporated. J.K.I. declares that he is bound by confidentiality agreements that prevent him from disclosing details of his financial interests in this work. J.H.V. and L.H.v.d.B. report to have sponsored research agreements with Biogen. E.H. is an inventor on pending patent family PCT/IL2016/050328 entitled &#x2018;Methods of treating motor neuron diseases&#x2019;. All other authors declare that they have no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Cooper-Knock</LastName><ForeName>Johnathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kenna</LastName><ForeName>Kevin P</ForeName><Initials>KP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hornstein</LastName><ForeName>Eran</ForeName><Initials>E</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35361972</ArticleId><ArticleId IdType="mid">EMS184427</ArticleId><ArticleId IdType="pmc">PMC7614916</ArticleId><ArticleId IdType="doi">10.1038/s41593-022-01040-6</ArticleId><ArticleId IdType="pii">10.1038/s41593-022-01040-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, van den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol. 2017;13:96&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53:1636&#x2013;1648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, Taylor JP. Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat Rev Genet. 2010;11:247&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4704680</ArticleId><ArticleId IdType="pubmed">20177426</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, et al. Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene. Cell Rep. 2020;33:108456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7710676</ArticleId><ArticleId IdType="pubmed">33264630</ArticleId></ArticleIdList></Reference><Reference><Citation>Povysil G, et al. Rare-variant collapsing analyses for complex traits: guidelines and applications. Nat Rev Genet. 2019;20:747&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pubmed">31605095</ArticleId></ArticleIdList></Reference><Reference><Citation>Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M. Mapping complex disease traits with global gene expression. Nat Rev Genet. 2009;10:184&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4550035</ArticleId><ArticleId IdType="pubmed">19223927</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight JC. Regulatory polymorphisms underlying complex disease traits. J Mol Med. 2005;83:97&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3132451</ArticleId><ArticleId IdType="pubmed">15592805</ArticleId></ArticleIdList></Reference><Reference><Citation>An JY, et al. Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder. Science. 2018;362:eaat6576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6432922</ArticleId><ArticleId IdType="pubmed">30545852</ArticleId></ArticleIdList></Reference><Reference><Citation>Haramati S, et al. miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci USA. 2010;107:13111&#x2013;13116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2919953</ArticleId><ArticleId IdType="pubmed">20616011</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A, et al. Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS. EMBO J. 2015;34:2633&#x2013;2651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4641530</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitan C, Hornstein E. Vulnerability of microRNA biogenesis in FTD-ALS. Brain Res. 2016;1647:105&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">26778173</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D, Droppelmann CA, He Z, Volkening K, Strong MJ. Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels. Mol Brain. 2013;6:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3668997</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, et al. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 2010;277:2268&#x2013;2281.</Citation><ArticleIdList><ArticleId IdType="pubmed">20423455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci USA. 2012;109:3347&#x2013;3352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Morlando M, et al. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 2012;31:4502&#x2013;4510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3545295</ArticleId><ArticleId IdType="pubmed">23232809</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoye ML, et al. MicroRNA profiling reveals marker of motor neuron disease in ALS models. J Neurosci. 2017;37:5574&#x2013;5586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5452343</ArticleId><ArticleId IdType="pubmed">28416596</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotem N, et al. ALS along the axons&#x2014;expression of coding and noncoding RNA differs in axons of ALS models. Sci Rep. 2017;7:44500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353576</ArticleId><ArticleId IdType="pubmed">28300211</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest. 2012;122:3063&#x2013;3087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, et al. Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Mol Cell Neurosci. 2016;71:34&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4761498</ArticleId><ArticleId IdType="pubmed">26704906</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AH, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326:1549&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3794896</ArticleId><ArticleId IdType="pubmed">19167326</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr C. Regulation by 3&#x2019;-untranslated regions. Annu Rev Genet. 2017;51:171&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">28853924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Abecasis GR, Boehnke M, Lin X. Rare-variant association analysis: study designs and statistical tests. Am J Hum Genet. 2014;95:5&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4085641</ArticleId><ArticleId IdType="pubmed">24995866</ArticleId></ArticleIdList></Reference><Reference><Citation>Alboni S, Cervia D, Sugama S, Conti B. Interleukin 18 in the CNS. J Neuroinflammation. 2010;7:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2830964</ArticleId><ArticleId IdType="pubmed">20113500</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, et al. TDP-43 activates microglia through NF-&#x3ba;B and NLRP3 inflammasome. Exp Neurol. 2015;273:24&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsutsumi N, et al. The structural basis for receptor recognition of human interleukin-18. Nat Commun. 2014;5:5340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4275594</ArticleId><ArticleId IdType="pubmed">25500532</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi O, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 1998;9:143&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">9697844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato Z, et al. The structure and binding mode of interleukin-18. Nat Struct Biol. 2003;10:966&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pubmed">14528293</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto S, et al. Interleukin-18 activates NF-&#x3ba;B in murine T helper type 1 cells. Biochem Biophys Res Commun. 1997;234:454&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">9177292</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson D, et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-&#x3b3; production and activates IRAK and NF&#x3ba;B. Immunity. 1997;7:571&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">9354477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima H, et al. An essential role for NF-&#x3ba;B in IL-18-induced IFN-&#x3b3; expression in KG-1 cells. J Immunol. 1999;162:5063&#x2013;5069.</Citation><ArticleIdList><ArticleId IdType="pubmed">10227974</ArticleId></ArticleIdList></Reference><Reference><Citation>Morel JC, Park CC, Kumar P, Koch AE. Interleukin-18 induces rheumatoid arthritis synovial fibroblast CXC chemokine production through NF&#x3ba;B activation. Lab Invest. 2001;81:1371&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">11598150</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyoshi K, Obata K, Kondo T, Okamura H, Noguchi K. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J Neurosci. 2008;28:12775&#x2013;12787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671812</ArticleId><ArticleId IdType="pubmed">19036970</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadhim H, Deltenre P, Martin JJ, Sebire G. In-situ expression of interleukin-18 and associated mediators in the human brain of sALS patients: hypothesis for a role for immune&#x2013;inflammatory mechanisms. Med Hypotheses. 2016;86:14&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">26804591</ArticleId></ArticleIdList></Reference><Reference><Citation>Johann S, et al. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia. 2015;63:2260&#x2013;2273.</Citation><ArticleIdList><ArticleId IdType="pubmed">26200799</ArticleId></ArticleIdList></Reference><Reference><Citation>Italiani P, et al. Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis. J Neuroinflammation. 2014;11:94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4039322</ArticleId><ArticleId IdType="pubmed">24884937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang F, et al. Longitudinal biomarkers in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2020;7:1103&#x2013;1116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359115</ArticleId><ArticleId IdType="pubmed">32515902</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D, Baloh RH. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J Clin Invest. 2017;127:3250&#x2013;3258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5669558</ArticleId><ArticleId IdType="pubmed">28737506</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Appel SH. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 2019;18:211&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahsen BF, et al. Non-neuronal cells in amyotrophic lateral sclerosis&#x2014; from pathogenesis to biomarkers. Nat Rev Neurol. 2021;17:333&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">33927394</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, Baloh RH. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137:715&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Motataianu A, Barcutean L, Balasa R. Neuroimmunity in amyotrophic lateral sclerosis: focus on microglia. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:159&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">31903792</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltschmidt B, Kaltschmidt C. NF-&#x3ba;B in the nervous system. Cold Spring Harb Perspect Biol. 2009;1:a001271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2773634</ArticleId><ArticleId IdType="pubmed">20066105</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP, Meffert MK. Roles for NF-&#x3ba;B in nerve cell survival, plasticity, and disease. Cell Death Differ. 2006;13:852&#x2013;860.</Citation><ArticleIdList><ArticleId IdType="pubmed">16397579</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Uranishi H, et al. Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-&#x3ba;B p65-mediated transcription as a coactivator. J Biol Chem. 2001;276:13395&#x2013;13401.</Citation><ArticleIdList><ArticleId IdType="pubmed">11278855</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor &#x3ba;B-mediated pathogenic pathways. J Exp Med. 2011;208:2429&#x2013;2447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Project MinE Consortium. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur J Hum Genet. 2017;26:1537&#x2013;1546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, et al. Optimal unified approach for rare-variant association testing with application to small-sample case&#x2013;control whole-exome sequencing studies. Am J Hum Genet. 2012;91:224&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3415556</ArticleId><ArticleId IdType="pubmed">22863193</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunckley T, et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med. 2007;357:775&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">17671248</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34:D140&#x2013;D144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1347474</ArticleId><ArticleId IdType="pubmed">16381832</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Jian X, Boerwinkle E. dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. Hum Mutat. 2013;34:E2393&#x2013;E2402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4109890</ArticleId><ArticleId IdType="pubmed">23843252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2016;48:1037&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, et al. Prevalence of SOD1 mutations in the Italian ALS population. Neurology. 2008;70:533&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pubmed">18268245</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek RAA, et al. The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:432&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893599</ArticleId><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Leary NA, et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016;44:D733&#x2013;D745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702849</ArticleId><ArticleId IdType="pubmed">26553804</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith L, et al. Establishing the UK DNA Bank for motor neuron disease (MND) BMC Genet. 2015;16:84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4501191</ArticleId><ArticleId IdType="pubmed">26170009</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;24:313&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Haukedal H, Freude K. Implications of microglia in amyotrophic lateral sclerosis and frontotemporal dementia. J Mol Biol. 2019;431:1818&#x2013;1829.</Citation><ArticleIdList><ArticleId IdType="pubmed">30763568</ArticleId></ArticleIdList></Reference><Reference><Citation>Haenseler W, et al. A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response. Stem Cell Reports. 2017;8:1727&#x2013;1742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5470330</ArticleId><ArticleId IdType="pubmed">28591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng SS, Chen CY, Xu N, Shyu AB. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 1998;17:3461&#x2013;3470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1170682</ArticleId><ArticleId IdType="pubmed">9628881</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan XC, Steitz JA. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 1998;17:3448&#x2013;3460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1170681</ArticleId><ArticleId IdType="pubmed">9628880</ArticleId></ArticleIdList></Reference><Reference><Citation>Stellos K, et al. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation. Nat Med. 2016;22:1140&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pubmed">27595325</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan CM, Steitz JA. HuR and mRNA stability. Cell Mol Life Sci. 2001;58:266&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">11289308</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Dominguez DJ, Morello D, Cisneros E, Kontoyiannis DL, Frade JM. Stabilization of Dll1 mRNA by Elavl1/HuR in neuroepithelial cells undergoing mitosis. Mol Biol Cell. 2011;22:1227&#x2013;1239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3078063</ArticleId><ArticleId IdType="pubmed">21346194</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothamel K, et al. ELAVL1 primarily couples mRNA stability with the 3&#x2019; UTRs of interferon-stimulated genes. Cell Rep. 2021;35:109178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8225249</ArticleId><ArticleId IdType="pubmed">34038724</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee N, et al. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol Cell. 2011;43:327&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220597</ArticleId><ArticleId IdType="pubmed">21723170</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandopulle MS, et al. Transcription factor-mediated differentiation of human iPSCs into neurons. Curr Protoc Cell Biol. 2018;79:e51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993937</ArticleId><ArticleId IdType="pubmed">29924488</ArticleId></ArticleIdList></Reference><Reference><Citation>Christian F, Smith EL, Carmody RJ. The regulation of NF-&#x3ba;B subunits by phosphorylation. Cells. 2016;5:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810097</ArticleId><ArticleId IdType="pubmed">26999213</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-&#x3ba;B determines its association with CBP/p300 or HDAC-1. Mol Cell. 2002;9:625&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">11931769</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-&#x3ba;B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell. 1998;1:661&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pubmed">9660950</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckinghaus A, Ghosh S. The NF-&#x3ba;B family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1:a000034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2773619</ArticleId><ArticleId IdType="pubmed">20066092</ArticleId></ArticleIdList></Reference><Reference><Citation>Waelchli R, et al. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK. Bioorg Med Chem Lett. 2006;16:108&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">16236504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers KL, et al. A loss of function variant in CASP7 protects against Alzheimer&#x2019;s disease in homozygous APOE &#x3b5;4 allele carriers. BMC Genomics. 2016;17:445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4928152</ArticleId><ArticleId IdType="pubmed">27358062</ArticleId></ArticleIdList></Reference><Reference><Citation>Benitez BA, et al. Missense variant in TREML2 protects against Alzheimer&#x2019;s disease. Neurobiol Aging. 2014;35:1510.:e19-26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3961557</ArticleId><ArticleId IdType="pubmed">24439484</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson T, et al. A mutation in APP protects against Alzheimer&#x2019;s disease and age-related cognitive decline. Nature. 2012;488:96&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">22801501</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims R, et al. Rare coding variants in PLCG2, ABI3 and TREM2 implicate microglial-mediated innate immunity in Alzheimer&#x2019;s disease. Nat Genet. 2017;49:1373&#x2013;1384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5669039</ArticleId><ArticleId IdType="pubmed">28714976</ArticleId></ArticleIdList></Reference><Reference><Citation>Landers JE, et al. Reduced expression of the kinesin-associated protein 3 KIFAP3 gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2009;106:9004&#x2013;9009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2683883</ArticleId><ArticleId IdType="pubmed">19451621</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhan SMK, et al. Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7 encoding a heat-shock protein. Nat Neurosci. 2019;22:1966&#x2013;1974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6919277</ArticleId><ArticleId IdType="pubmed">31768050</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrechts D, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003;34:383&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">12847526</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenstein I, et al. Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology. Sci Transl Med. 2019;11:eaav5264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7057809</ArticleId><ArticleId IdType="pubmed">31852800</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47:W199&#x2013;W205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602449</ArticleId><ArticleId IdType="pubmed">31114916</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz R, et al. ViennaRNA package 2.0. Algorithms Mol Biol. 2011;6:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3319429</ArticleId><ArticleId IdType="pubmed">22115189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan X, Hu Y, Li B, Abecasis GR, Liu DJ. RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data. Bioinformatics. 2016;32:1423&#x2013;1426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4848408</ArticleId><ArticleId IdType="pubmed">27153000</ArticleId></ArticleIdList></Reference><Reference><Citation>Raczy C, et al. Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms. Bioinformatics. 2013;29:2041&#x2013;2043.</Citation><ArticleIdList><ArticleId IdType="pubmed">23736529</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyner C, et al. The UCSC Genome Browser database: 2017 update. Nucleic Acids Res. 2017;45:D626&#x2013;D634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210591</ArticleId><ArticleId IdType="pubmed">27899642</ArticleId></ArticleIdList></Reference><Reference><Citation>Danecek P, et al. The variant call format and VCFtools. Bioinformatics. 2011;27:2156&#x2013;2158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137218</ArticleId><ArticleId IdType="pubmed">21653522</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2938201</ArticleId><ArticleId IdType="pubmed">20601685</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4:e05005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4532895</ArticleId><ArticleId IdType="pubmed">26267216</ArticleId></ArticleIdList></Reference><Reference><Citation>Schildge S, Bohrer C, Beck K, Schachtrup C. Isolation and culture of mouse cortical astrocytes. J Vis Exp. 2013 doi: 10.3791/50079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/50079</ArticleId><ArticleId IdType="pmc">PMC3582677</ArticleId><ArticleId IdType="pubmed">23380713</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu PD, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013;31:827&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969858</ArticleId><ArticleId IdType="pubmed">23873081</ArticleId></ArticleIdList></Reference><Reference><Citation>Doench JG, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR&#x2013;Cas9. Nat Biotechnol. 2016;34:184&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4744125</ArticleId><ArticleId IdType="pubmed">26780180</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, et al. Sequence determinants of improved CRISPR sgRNA design. Genome Res. 2015;25:1147&#x2013;1157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4509999</ArticleId><ArticleId IdType="pubmed">26063738</ArticleId></ArticleIdList></Reference><Reference><Citation>Chari R, Mali P, Moosburner M, Church GM. Unraveling CRISPR-Cas9 genome engineering parameters via a library-on-library approach. Nat Methods. 2015;12:823&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5292764</ArticleId><ArticleId IdType="pubmed">26167643</ArticleId></ArticleIdList></Reference><Reference><Citation>Erijman A, Dantes A, Bernheim R, Shifman JM, Peleg Y. Transfer-PCR (TPCR): a highway for DNA cloning and protein engineering. J Struct Biol. 2011;175:171&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">21515384</ArticleId></ArticleIdList></Reference><Reference><Citation>Peleg Y, Unger T. Application of the restriction-free (RF) cloning for multicomponents assembly. Methods Mol Biol. 2014;1116:73&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">24395358</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, et al. MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing. Nat Protoc. 2019;14:1841&#x2013;1862.</Citation><ArticleIdList><ArticleId IdType="pubmed">31101904</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaitin DA, et al. Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types. Science. 2014;343:776&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4412462</ArticleId><ArticleId IdType="pubmed">24531970</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohen R, et al. UTAP: user-friendly transcriptome analysis pipeline. BMC Bioinformatics. 2019;20:154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6434621</ArticleId><ArticleId IdType="pubmed">30909881</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367&#x2013;1372.</Citation><ArticleIdList><ArticleId IdType="pubmed">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Mann M. Quantitative, high-resolution proteomics for data-driven systems biology. Annu Rev Biochem. 2011;80:273&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">21548781</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Michalski A, Mann M. Software lock mass by two-dimensional minimization of peptide mass errors. J Am Soc Mass Spectrom. 2011;22:1373&#x2013;1380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3231580</ArticleId><ArticleId IdType="pubmed">21953191</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics. 2014;13:2513&#x2013;2526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159666</ArticleId><ArticleId IdType="pubmed">24942700</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyanova S, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13:731&#x2013;740.</Citation><ArticleIdList><ArticleId IdType="pubmed">27348712</ArticleId></ArticleIdList></Reference><Reference><Citation>Krach F, et al. Transcriptome&#x2013;pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS. Acta Neuropathol. 2018;136:405&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6215775</ArticleId><ArticleId IdType="pubmed">29881994</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson L. iMN (Exp 2)&#x2014;ALS, SMA and control (unaffected) iMN cell lines differentiated from iPS cell lines using a long differentiation protocol&#x2014;RNA-seq LINCS (collection) 2017 
 http://identifiers.org/lincs.data/LDG-1338
.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>